← Browse by Condition
Medical Condition

h3 k27m

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT05580562 Phase 3
Recruiting

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

Enrollment
450 pts
Location
United States, Argen...
Sponsor
Jazz Pharmaceuticals
View Trial →